Nanomedicine News

RSS

Case Western Receives Grant for Study on Nanotechnology for Treatment of Pediatric Glioma Brain Tumors

Prayers from Maria Children's Glioma Cancer Foundation announced today that it will award its $250,000 Melana Matson Memorial Grant—its third major research grant since 2010—to Case Western Reserve University, Case Comprehensive Cancer Center researchers James Basilion, PhD, Efstathis Karathanasis, PhD, and John Letterio, MD, who are studying the use of nanotechnology to more effectively treat pediatric glioma brain tumors.

28 Oct 2014

USAMRIID Scientists to Evaluate Nanoviricides Anti-Ebola Drug Candidates

NanoViricides, Inc., a nanomedicine company developing anti-viral drugs, announced today that it has executed a CRADA (Collaborative Research and Development Agreement for Material Transfer) with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID).

From NanoViricides, Inc 28 Oct 2014

New Data from Novavax' RSV F-Protein Nanoparticle Vaccine Trial Presented at 8th Vaccine & ISV Congress

Novavax, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, announced today that Gregory Glenn, M.D., SVP, Research and Development is presenting new immunogenicity data from Novavax' RSV F-Protein Nanoparticle vaccine candidate (RSV F vaccine) clinical trials at the 8th Vaccine & ISV Congress in Philadelphia, PA.

From Novavax Inc. 27 Oct 2014

NanoSIMS Helps Trace How Liver, Brain Cells Store and Metabolize Glycogen

Scientists at EPFL have used a new imaging technique to monitor how glucose, our main energy source, is used in the body. Their findings may have great implications for diseases like diabetes.

27 Oct 2014

Nanoscale Device Can Rapidly Gauge Optimal Dose of Potentially Toxic Cancer Drug

In less than a minute, a miniature device developed at the University of Montreal can measure a patient's blood for methotrexate, a commonly used but potentially toxic cancer drug. Just as accurate and ten times less expensive than equipment currently used in hospitals, this nanoscale device has an optical system that can rapidly gauge the optimal dose of methotrexate a patient needs, while minimizing the drug's adverse effects. The research was led by Jean-François Masson and Joelle Pelletier of the university's Department of Chemistry.

27 Oct 2014

CASIS Awards Grant to Develop Remotely Controlled Nanochannel Drug Delivery System

Houston Methodist Research Institute scientists will receive about $1.25 million from the Center for the Advancement of Science in Space to develop an implantable device that delivers therapeutic drugs at a rate guided by remote control. The device's effectiveness will be tested aboard the International Space Station and on Earth's surface.

27 Oct 2014

Novel Nanoparticle Delivers Melanoma-Fighting Drug Directly to the Cancer

Penn State College of Medicine researchers have developed a nanoparticle to deliver a melanoma-fighting drug directly to the cancer.

25 Oct 2014

New Report on Global Market for Anti-Microbial Nanocoatings

Research and Markets has announced the addition of the "The Global Market for Anti-Microbial Nanocoatings" report to their offering.

25 Oct 2014

Smarter, More Targeted Nanotherapy Could Overcome Lethal Gynecologic Cancer

Physicians will tell you: They are not winning the war on ovarian cancer. But Florida International University researchers are crafting a new weapon for that battle. A group of scientists have combined medicine and advanced nanotechnological engineering to create a smarter, more targeted therapy that could overcome the most lethal gynecologic cancer.

25 Oct 2014

Tiny ‘Nanodomain’ Structures with Concentrated ANK3 Gene Levels Linked to Bipolar Disorder

A nano-sized discovery by Northwestern Medicine® scientists helps explain how bipolar disorder affects the brain and could one day lead to new drug therapies to treat the mental illness.

24 Oct 2014